We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$3.69B
AUM Growth
+$319M
Cap. Flow
+$89M
Cap. Flow %
2.41%
Top 10 Hldgs %
34.5%
Holding
3,484
New
163
Increased
1,467
Reduced
808
Closed
181

Sector Composition

Rank Sector Weight
1 Technology 15.28%
2 Healthcare 8.29%
3 Financials 6.97%
4 Communication Services 4.77%
5 Consumer Discretionary 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVTA
3226
DELISTED
Invitae Corporation
NVTA
$46 ﹤0.01%
4,168
-1,000
-19% -$455
CRVS icon
3227
Corvus Pharmaceuticals
CRVS
$1.17B
$36 ﹤0.01%
20
RENT
3228
Rent the Runway
RENT
$124M
$35 ﹤0.01%
5
CMAX
3229
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$34 ﹤0.01%
7
+1
+17% +$8
ALZN icon
3230
Alzamend Neuro
ALZN
$6.56M
0
CCSI icon
3231
Consensus Cloud Solutions
CCSI
$647M
$32 ﹤0.01%
2
-80
-98% -$1.43K
RBBN icon
3232
Ribbon Communications
RBBN
$383M
$32 ﹤0.01%
+10
New +$30
RAD
3233
DELISTED
Rite Aid Corporation
RAD
$32 ﹤0.01%
200
EIS icon
3234
iShares MSCI Israel ETF
EIS
$909M
0
USAS
3235
Americas Gold and Silver
USAS
$1.69B
$29 ﹤0.01%
52
HYLN icon
3236
Hyliion Holdings
HYLN
$690M
$25 ﹤0.01%
14
MVST icon
3237
Microvast
MVST
$302M
$25 ﹤0.01%
30
AVTX icon
3238
Avalo Therapeutics
AVTX
$983M
$22 ﹤0.01%
+1
New +$5
OABI icon
3239
OmniAb
OABI
$447M
$22 ﹤0.01%
4
ONL
3240
Orion Office REIT
ONL
$160M
$21 ﹤0.01%
6
-309
-98% -$1.39K
RXRX icon
3241
Recursion Pharmaceuticals
RXRX
$1.73B
$20 ﹤0.01%
2
KBE icon
3242
State Street SPDR S&P Bank ETF
KBE
$1.66B
0
AKTS
3243
DELISTED
Akoustis Technologies Inc
AKTS
$18 ﹤0.01%
30
DOMA
3244
DELISTED
Doma Holdings, Inc.
DOMA
$18 ﹤0.01%
4
ECF
3245
Ellsworth Growth & Income Fund
ECF
$172M
$17 ﹤0.01%
2
SEEL
3246
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
AKO.B icon
3247
Embotelladora Andina Series B
AKO.B
$4.95B
$15 ﹤0.01%
+1
New +$15
NAVB
3248
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$13 ﹤0.01%
350
EHAB
3249
DELISTED
Enhabit
EHAB
$12 ﹤0.01%
1
AAGR
3250
DELISTED
African Agriculture Holdings Inc
AAGR
$12 ﹤0.01%
30

Similar funds

Parallel Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Parallel Advisors held 3,484 positions worth $3.69B, up 9.5% from $3.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors's Q1 2024 filing shows 163 new, 1,467 increased, 808 reduced and 181 closed positions. Its largest new stake was Janus Henderson Mortgage-Backed Securities ETF: 338,790 shares worth $15.3M. The largest sale was iShares Core S&P Total US Stock Market ETF, an estimated $43.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q1 2024 buy was Janus Henderson Mortgage-Backed Securities ETF: 338,790 shares worth $15.3M.
  • Parallel Advisors added most to Invesco S&P 500 Equal Weight ETF in Q1 2024, an estimated $50.7M increase.
  • Parallel Advisors's biggest Q1 2024 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $43.6M.
  • Parallel Advisors fully exited Lions Gate Entertainment Corp. Class B Non-Voting Shares in Q1 2024, selling an estimated $335K.
  • Parallel Advisors's ten largest holdings make up 35% of its $3.69B portfolio in Q1 2024.
  • Parallel Advisors opened 163 new positions and closed 181 in Q1 2024.
  • Parallel Advisors's portfolio value rose 9.5% quarter-over-quarter to $3.69B.

Based on Parallel Advisors's 13F filing for Q1 2024, filed 6 May 2024.